ArticleAlzheimer's & dementia (New York, N. Y.)

SHIP1 therapeutic target enablement: Identification and evaluation of inhibitors for the treatment of late-onset Alzheimer's disease.

Cynthia D Jesudason et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.